Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lymphoma 54Lymphoma, Large B-Cell, Diffuse 49Lymphoma, Non-Hodgkin 48Lymphoma, Mantle-Cell 37Lymphoma, Follicular 32Hodgkin Disease 28Lymphoma, Large-Cell, Immunoblastic 23Burkitt Lymphoma 22Leukemia, Lymphocytic, Chronic, B-Cell 21Glioblastoma 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Multiple Myeloma 17Lymphoma, B-Cell, Marginal Zone 15Gliosarcoma 15Brain Neoplasms 15Central Nervous System Neoplasms 14Neoplasms, Plasma Cell 11Glioma 11Astrocytoma 11Leukemia 10Lymphoma, B-Cell 9Recurrence 7Lymphoma, T-Cell 7Waldenstrom Macroglobulinemia 5Oligodendroglioma 5Lymphoma, T-Cell, Peripheral 5Lymphoma, T-Cell, Cutaneous 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Acute 4

Interventions

Cyclophosphamide 21Cytarabine 15blinatumomab 13fludarabine 12Azacitidine 10venetoclax 9fludarabine phosphate 9Blood Specimen Collection 8Methotrexate 7Lenalidomide 7Dexamethasone 7Rituximab 6Mercaptopurine 6Daunorubicin 6Vincristine 5daratumumab 4Whole-Body Irradiation 4Melphalan 4Etoposide 4Busulfan 4obinutuzumab 3Radiotherapy 3Neoadjuvant Therapy 3Maintenance 3Liquid Biopsy 3Immunotherapy, Adoptive 3Idarubicin 3Granulocyte Colony-Stimulating Factor 3Drug Therapy 3Doxorubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasm, Residual × Carmustine × Clear all
NCT02670109 2020-01-14

Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Phase 2 Unknown
20 enrolled
Tumor-Agnostic

Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡